Praziquantel is used to treat diseases caused by infection with several types of internal/gastrointestinal, and external parasites, including:
The majority of side effects develop due to the release of the contents of the parasites as they are killed and the consequent host immune reaction. The heavier the parasite burden, the heavier and more frequent the side effects normally are.
The WHO states praziquantel is safe during pregnancy (although does not recommend use during the first trimester). Animal studies have failed to reveal evidence of fetal harm. Praziquantel is effective in reducing schistosomiasis during pregnancy. Another trial found that treatment with praziquantel did not increase the rates of low birthweight, fetal death, or congenital anomalies.
The drug's mode of action is not exactly known at present, but experimental evidence indicates praziquantel increases the permeability of the membranes of schistosome cells towards calcium ions. The drug thereby induces contraction of the parasites' muscle, resulting in paralysis in the contracted state. The dying parasites are dislodged from their site of action in the host organism and may enter systemic circulation or may be destroyed by host immune reaction (phagocytosis). Additional mechanisms including focal disintegrations and disturbances of oviposition (laying of eggs) are seen in other types of sensitive parasites.
Bayer's Animal Health Division website states, "Praziquantel is active against cestodes (tapeworms). Praziquantel is absorbed, metabolized in the liver, and excreted in the bile. Upon entering the digestive tract from the bile, cestocidal activity is exhibited. Following exposure to praziquantel, the tapeworm loses its ability to resist digestion by the mammalian host. Because of this, whole tapeworms, including the scolices (plural of "scolex"), are very rarely passed after administration of praziquantel. In many instances, only disintegrated and partially digested pieces of tapeworms will be seen in the stool. The majority of tapeworms are digested and are not found in the feces."
Praziquantel is on the World Health Organization's List of Essential Medicines.
Praziquantel is not licensed for use in humans in the UK, but it can be imported when necessary on a named-patient basis. It is available in the UK as a veterinary anthelmintic.
Praziquantel is approved in the US for the treatment of schistosomiasis and liver flukes, although it is effective in other infections.
"Praziquantel". The American Society of Health-System Pharmacists. Archived from the original on 20 December 2016. Retrieved 8 December 2016. https://www.drugs.com/monograph/praziquantel.html
"Praziquantel". The American Society of Health-System Pharmacists. Archived from the original on 20 December 2016. Retrieved 8 December 2016. https://www.drugs.com/monograph/praziquantel.html
World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. pp. 88, 593. hdl:10665/44053. ISBN 9789241547659. 9789241547659
"Praziquantel". The American Society of Health-System Pharmacists. Archived from the original on 20 December 2016. Retrieved 8 December 2016. https://www.drugs.com/monograph/praziquantel.html
World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. pp. 88, 593. hdl:10665/44053. ISBN 9789241547659. 9789241547659
World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. pp. 88, 593. hdl:10665/44053. ISBN 9789241547659. 9789241547659
"Praziquantel". The American Society of Health-System Pharmacists. Archived from the original on 20 December 2016. Retrieved 8 December 2016. https://www.drugs.com/monograph/praziquantel.html
"Praziquantel". The American Society of Health-System Pharmacists. Archived from the original on 20 December 2016. Retrieved 8 December 2016. https://www.drugs.com/monograph/praziquantel.html
"Praziquantel". The American Society of Health-System Pharmacists. Archived from the original on 20 December 2016. Retrieved 8 December 2016. https://www.drugs.com/monograph/praziquantel.html
World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. hdl:10665/371090. WHO/MHP/HPS/EML/2023.02. /wiki/World_Health_Organization
Matthaiou DK, Panos G, Adamidi ES, Falagas ME (March 2008). Carabin H (ed.). "Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials". PLOS Neglected Tropical Diseases. 2 (3): e194. doi:10.1371/journal.pntd.0000194. PMC 2265431. PMID 18335068. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265431
"CDC - Taeniasis - Resources for Health Professionals". CDC. 20 May 2020. Retrieved 2 May 2024. https://www.cdc.gov/parasites/taeniasis/health_professionals/index.html
"CDC - Diphyllobothrium - Resources for Health Professionals". CDC. 20 May 2020. Retrieved 2 May 2024. https://www.cdc.gov/parasites/diphyllobothrium/health_professionals/index.html
"CDC - Hymenolepis - Resources for Health Professionals". CDC. 20 May 2020. Retrieved 2 May 2024. https://www.cdc.gov/parasites/hymenolepis/health_professionals/index.html
"CDC - DPDx - Bertiella infection - Treatment Information". CDC. 29 November 2013. Retrieved 2 May 2024. https://www.cdc.gov/dpdx/bertiella/tx.html
Drontal Data Sheet; Drontal Cat & Cat XL Film-coated Tablets, Bayer plc (PDF), Newbury, England: Bayer plc, Animal Health Division, p. 2, archived (PDF) from the original on 23 September 2015, retrieved 23 September 2015 https://www.drontal.com/static/drontal/DrontalCat&CatXLFilm-coatedTablets.pdf
Bowman DD, Hendrix CM, Lindsay DS, Barr SC (2002). Feline clinical parasitology (First ed.). Ames, Iowa: Iowa State University. p. 275. ISBN 0-8138-0333-0. Archived from the original on 10 September 2017. 0-8138-0333-0
Drontal Data Sheet; Drontal Cat & Cat XL Film-coated Tablets, Bayer plc (PDF), Newbury, England: Bayer plc, Animal Health Division, p. 2, archived (PDF) from the original on 23 September 2015, retrieved 23 September 2015 https://www.drontal.com/static/drontal/DrontalCat&CatXLFilm-coatedTablets.pdf
Bowman DD, Hendrix CM, Lindsay DS, Barr SC (2002). Feline clinical parasitology (First ed.). Ames, Iowa: Iowa State University. p. 275. ISBN 0-8138-0333-0. Archived from the original on 10 September 2017. 0-8138-0333-0
Drontal Data Sheet; Drontal Cat & Cat XL Film-coated Tablets, Bayer plc (PDF), Newbury, England: Bayer plc, Animal Health Division, p. 2, archived (PDF) from the original on 23 September 2015, retrieved 23 September 2015 https://www.drontal.com/static/drontal/DrontalCat&CatXLFilm-coatedTablets.pdf
Tchuenté LA, Shaw DJ, Polla L, Cioli D, Vercruysse J (December 2004). "Efficacy of praziquantel against Schistosoma haematobium infection in children". The American Journal of Tropical Medicine and Hygiene. 71 (6): 778–782. doi:10.4269/ajtmh.2004.71.778. PMID 15642971. https://doi.org/10.4269%2Fajtmh.2004.71.778
The Carter Center. "Schistosomiasis Control Program". Archived from the original on 20 July 2008. Retrieved 17 July 2008. http://www.cartercenter.org/health/schistosomiasis/index.html
Shen C, Kim J, Lee JK, Bae YM, Choi MH, Oh JK, et al. (June 2007). "Collection of Clonorchis sinensis adult worms from infected humans after praziquantel treatment". The Korean Journal of Parasitology. 45 (2): 149–152. doi:10.3347/kjp.2007.45.2.149. PMC 2526309. PMID 17570980. Archived from the original on 20 December 2012. https://archive.today/20121220070503/http://www.parasitol.or.kr/kjp/abstracts/2007_149.html
"Opisthorchiasis - Treatment Information". CDC - DPDx. 29 November 2013. Retrieved 7 September 2015. https://www.cdc.gov/dpdx/opisthorchiasis/tx.html
"CDC - Paragonimiasis - General Information - Frequently Asked Questions (FAQs)". www.cdc.gov. 19 April 2019. Retrieved 2 October 2019. https://www.cdc.gov/parasites/paragonimus/gen_info/faqs.html
"CDC - Paragonimiasis - Resources for Health Professionals". www.cdc.gov. 24 May 2019. Retrieved 2 October 2019. https://www.cdc.gov/parasites/paragonimus/health_professionals/index.html
Mas-Coma S, Bargues MD, Valero MA (October 2005). "Fascioliasis and other plant-borne trematode zoonoses". International Journal for Parasitology. 35 (11–12): 1255–1278. doi:10.1016/j.ijpara.2005.07.010. PMID 16150452. /wiki/Doi_(identifier)
Toledo R, Álvarez-Izquierdo M, Guillermo-Esteban J, Muñoz-Antoli C (March 2022). "Neglected food-borne trematodiases: echinostomiasis and gastrodiscoidiasis". Parasitology. 149 (10): 1319–1326. doi:10.1017/s0031182022000385. PMC 10090775. PMID 35343418. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090775
Rim HJ, Chu DS, Lee JS, Joo KH, Won CY (December 1978). "[Anthelmintic Effects Of Various Drugs Against Metagonimiasis]". Kisaengch'unghak Chapchi. The Korean Journal of Parasitology. 16 (2): 117–122. doi:10.3347/kjp.1978.16.2.117. PMID 12902772. /wiki/Doi_(identifier)
Taraschewski H, Mehlhorn H, Bunnag D, Andrews P, Thomas H (November 1986). "Effects of praziquantel on human intestinal flukes (Fasciolopsis buski and Heterophyes heterophyes)". Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene. Series A: Medical Microbiology, Infectious Diseases, Virology, Parasitology. 262 (4): 542–550. doi:10.1016/s0176-6724(86)80148-1. PMID 3799097. /wiki/Doi_(identifier)
Toledo R, Álvarez-Izquierdo M, Guillermo-Esteban J, Muñoz-Antoli C (March 2022). "Neglected food-borne trematodiases: echinostomiasis and gastrodiscoidiasis". Parasitology. 149 (10): 1319–1326. doi:10.1017/s0031182022000385. PMC 10090775. PMID 35343418. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090775
"WHO } Guideline". World Health Organisation: Schistosomiasis. Archived from the original on 17 June 2007. Retrieved 4 March 2020. https://web.archive.org/web/20070617184031/http://www.who.int/schistosomiasis/strategy/en/
"WHO } Strategy" (PDF). WHO (2022) "WHO Guideline on control and elimination of human schistosomiasis" ISBN 978-92-4-004160-8. Retrieved 2 October 2024. https://www.ncbi.nlm.nih.gov/books/NBK578392/pdf/Bookshelf_NBK578392.pdf
Tweyongyere R, Mawa PA, Emojong NO, Mpairwe H, Jones FM, Duong T, et al. (March 2009). "Effect of praziquantel treatment of Schistosoma mansoni during pregnancy on intensity of infection and antibody responses to schistosome antigens: results of a randomised, placebo-controlled trial". BMC Infectious Diseases. 9 (32): 32. doi:10.1186/1471-2334-9-32. PMC 2666740. PMID 19296834. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2666740
Olveda RM, Acosta LP, Tallo V, Baltazar PI, Lesiguez JL, Estanislao GG, et al. (February 2016). "Efficacy and safety of praziquantel for the treatment of human schistosomiasis during pregnancy: a phase 2, randomised, double-blind, placebo-controlled trial". The Lancet. Infectious Diseases. 16 (2): 199–208. doi:10.1016/S1473-3099(15)00345-X. PMC 4752899. PMID 26511959. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752899
Ridtitid W, Wongnawa M, Mahatthanatrakul W, Punyo J, Sunbhanich M (November 2002). "Rifampin markedly decreases plasma concentrations of praziquantel in healthy volunteers". Clinical Pharmacology and Therapeutics. 72 (5): 505–513. doi:10.1067/mcp.2002.129319. PMID 12426514. S2CID 30853881. /wiki/Doi_(identifier)
Quinn DI, Day RO (June 1995). "Drug interactions of clinical importance. An updated guide". Drug Safety. 12 (6): 393–452. doi:10.2165/00002018-199512060-00005. PMID 8527014. S2CID 34890344. /wiki/Doi_(identifier)
Masimirembwa CM, Naik YS, Hasler JA (January 1994). "The effect of chloroquine on the pharmacokinetics and metabolism of praziquantel in rats and in humans". Biopharmaceutics & Drug Disposition. 15 (1): 33–43. doi:10.1002/bdd.2510150103. PMID 8161714. S2CID 45098166. /wiki/Doi_(identifier)
Metwally A, Bennett JL, Botros S, Ebeid F (April 1995). "Effect of cimetidine, bicarbonate and glucose on the bioavailability of different formulations of praziquantel". Arzneimittel-Forschung. 45 (4): 516–518. PMID 7779153. /wiki/PMID_(identifier)
Jung H, Medina R, Castro N, Corona T, Sotelo J (June 1997). "Pharmacokinetic study of praziquantel administered alone and in combination with cimetidine in a single-day therapeutic regimen". Antimicrobial Agents and Chemotherapy. 41 (6): 1256–1259. doi:10.1128/AAC.41.6.1256. PMC 163896. PMID 9174180. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC163896
Angelucci F, Basso A, Bellelli A, Brunori M, Pica Mattoccia L, Valle C (August 2007). "The anti-schistosomal drug praziquantel is an adenosine antagonist". Parasitology. 134 (Pt 9): 1215–1221. doi:10.1017/S0031182007002600. PMID 17428352. S2CID 22482704. /wiki/Doi_(identifier)
"Archived copy". Archived from the original on 18 May 2007. Retrieved 24 March 2010.{{cite web}}: CS1 maint: archived copy as title (link)[full citation needed] https://web.archive.org/web/20070518114008/http://bayer.naccvp.com/view_label.php
Woelfle M, Seerden JP, de Gooijer J, Pouwer K, Olliaro P, Todd MH (September 2011). Geary TG (ed.). "Resolution of praziquantel". PLOS Neglected Tropical Diseases. 5 (9): e1260. doi:10.1371/journal.pntd.0001260. PMC 3176743. PMID 21949890. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176743
The Carter Center. "Schistosomiasis Control Program". Archived from the original on 20 July 2008. Retrieved 17 July 2008. http://www.cartercenter.org/health/schistosomiasis/index.html
"BILTRICIDE- praziquantel tablet, film coated (NDC Code(s): 50419-747-01)". DailyMed. July 2015. Archived from the original on 10 September 2015. Retrieved 8 September 2015. http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=34ce1cdd-648e-4f1e-8512-bf3d4cc22eb9
World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. hdl:10665/371090. WHO/MHP/HPS/EML/2023.02. /wiki/World_Health_Organization
"Antihelmintics - Medicines for Worms; threadword, roundworm". Patient. Archived from the original on 18 June 2015. Retrieved 15 June 2015. https://patient.info//health/antihelmintics-medicines-for-worms
Brunton L, Chabner B, Knollman B (10 January 2011). Goodman and Gilman's The Pharmacological Basis of Therapeutics, Twelfth Edition (12 ed.). New York: McGraw-Hill Education / Medical. ISBN 9780071624428.[page needed] 9780071624428
Schmahl G, Taraschewski H (1987). "Treatment of fish parasites. 2. Effects of praziquantel, niclosamide, levamisole-HCl, and metrifonate on monogenea (Gyrodactylus aculeati, Diplozoon paradoxum)". Parasitology Research. 73 (4): 341–351. doi:10.1007/bf00531089. PMID 3615395. S2CID 12241452. /wiki/Doi_(identifier)
"Prazivetin EPAR". European Medicines Agency (EMA). 13 March 2025. Retrieved 19 March 2025. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged. https://www.ema.europa.eu/en/medicines/veterinary/EPAR/prazivetin
"Prazivetin EPAR". European Medicines Agency (EMA). 13 March 2025. Retrieved 19 March 2025. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged. https://www.ema.europa.eu/en/medicines/veterinary/EPAR/prazivetin
"Prazivetin EPAR". European Medicines Agency (EMA). 13 March 2025. Retrieved 19 March 2025. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged. https://www.ema.europa.eu/en/medicines/veterinary/EPAR/prazivetin